By last fall, there were increasing signs that Hims & Hers’s ability to sell its imitation semaglutide was nearing an end. The FDA in October said the shortage of Eli Lilly’s weight-loss drug ...

Weight loss drugs are getting more popular, even for teenagers and pre-teens -- but while many doctors have reported ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Hims & Hers Health announced today that it has entered into “a long-term collaboration” with Danish drugmaker Novo Nordisk to offer its popular weight-loss drug Wegovy to its users through the ...

The ad then promoted Hims & Hers' weight loss products ... companies took a hit when the Food and Drug Administration (FDA) announced that semaglutide was no longer in short supply, making ...

That partnership will see Hims & Hers offer Novo Nordisk’s weight-loss drug Wegovy ... a compounded semaglutide due to a semaglutide shortage. But once the U.S. Food and Drug Administration ...

Hims & Hers started prescribing compounded semaglutide, the active ingredient in Novo Nordisk's diabetes drug Ozempic and Wegovy, in May of 2024. The company has largely had to stop offering the ...